SCHEMBL2010899

SCHEMBL2010899

Cc1cc2occc2nc1C#N

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.40
DYRK1A Q13627 1/20 0.35
PSMB8 P28062 2/20 0.33
PSMB5 P28074 1/20 0.33
MAPK14 Q16539 1/20 0.32
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 3/20 0.31
GAA P10253 3/20 0.31
HPGD P15428 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MEN1 O00255 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.31
MAPK1 P28482 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
USP8 P40818 1/20 0.30
USP7 Q93009 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17234682 0.73 DYRK1A (0.38) DYRK1AKDM4EALDH1A1MEN1MAPT
SCHEMBL30370935 0.73 DYRK1A (0.38) DYRK1AKDM4EALDH1A1MEN1MAPT
SCHEMBL31314315 0.69 TDP1 (0.53) DYRK1AMAPK14KDM4EALDH1A1GAA
SCHEMBL4744938 0.69 TDP1 (0.53) DYRK1AMAPK14KDM4EALDH1A1GAA
SCHEMBL6917872 0.68 ALDH1A1 (0.40) DYRK1AKDM4EALDH1A1GAAHSD17B10
SCHEMBL30577635 0.67 CYP2A6 (0.48) CYP2A6DYRK1APSMB8PSMB5
SCHEMBL14629332 0.67 CYP2A6 (0.48) CYP2A6DYRK1APSMB8PSMB5
SCHEMBL30896559 0.66 DYRK1A (0.38) DYRK1AKDM4EALDH1A1HSD17B10MEN1
SCHEMBL22792965 0.64 DYRK1A (0.37) DYRK1AMAPT
SCHEMBL8122154 0.64 CYP2A6 (0.46) CYP2A6KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed